{"disease":{"id":"hearing-loss-ototoxic","name":"hearing loss ototoxic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06551857","title":"The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Turku University Hospital","has_results":false},{"nct_id":"NCT01451853","title":"SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Sound Pharmaceuticals, Incorporated","has_results":false},{"nct_id":"NCT05628233","title":"SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Sensorion","has_results":false},{"nct_id":"NCT07364747","title":"Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Siriraj Hospital","has_results":false},{"nct_id":"NCT04226456","title":"Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":19,"lead_sponsor_name":"Centre Hospitalier Universitaire Saint Pierre","has_results":false},{"nct_id":"NCT04766853","title":"Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Seoul National University Hospital","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}